CDK1 and pancreatic neoplasm: Furthermore, CDK1 might phosphorylate TOP2A to promote S phase transition and influence the progression of pancreatic cancer, but follow-up research is needed to determine the specific mechanism of the interaction (Kalimutho et al., 2018).